KK
IRON icon

KLP Kapitalforvaltning’s Disc Medicine IRON Stock Holding History

KLP Kapitalforvaltning’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$380K Hold
5,200
– – ﹤0.01% 1633
2026
Q1 		$332K Hold
5,200
– – ﹤0.01% 1614
2025
Q4 		$413K Buy
5,200
+600
+13% +$50.7K ﹤0.01% 1500
2025
Q3 		$304K Hold
4,600
– – ﹤0.01% 1643
2025
Q2 		$244K Buy
4,600
+900
+24% +$42.3K ﹤0.01% 1697
2025
Q1 		$184K Hold
3,700
– – ﹤0.01% 1784
2024
Q4 		$235K Buy
+3,700
New +$214K ﹤0.01% 1753

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KLP Kapitalforvaltning's IRON Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Disc Medicine (IRON) position steady in Q2 2026 at 5,200 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

KLP Kapitalforvaltning first reported a position in IRON in Q4 2024 and has held it in 7 quarters since. The position peaked at $413K in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • KLP Kapitalforvaltning held 5,200 shares of Disc Medicine worth $380K as of Q2 2026.
  • KLP Kapitalforvaltning left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1633 holding.
  • KLP Kapitalforvaltning first reported a position in Disc Medicine in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Disc Medicine position peaked at $413K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.